Clinical Applications of Otoacoustic Emissions

1991 ◽  
Vol 34 (5) ◽  
pp. 964-981 ◽  
Author(s):  
Brenda L. Lonsbury-Martin ◽  
Martin L. Whitehead ◽  
Glen K. Martin
Keyword(s):  
Otoacoustic Emissions ◽  
Present Report ◽  
Clinical Applications ◽  
Distortion Product Otoacoustic Emissions ◽  
Current View ◽  
Cochlear Function ◽  
Distortion Product ◽  
Auditory Physiology ◽  
Clinical Potential

On the basis of recent advances in auditory physiology, new tests of cochlear function have been developed using measures of otoacoustic emissions. In the present report, the clinical potential for each of the four basic emission types is examined. In addition, the practical advantages of examining the ear with two specific types of evoked emissions, transiently evoked and distortion-product otoacoustic emissions, are reviewed in detail. Finally, the future role of tests of otoacoustic emissions in the diagnosis of hearing impairment is discussed. The current view is that evoked emissions hold promise as an essential part of the clinical examination of the auditory system.

Evaluating cochlear function and the effects of noise exposure in the B6.CAST+Ahl mouse with distortion product otoacoustic emissions

2004 ◽  
Vol 194 (1-2) ◽  
pp. 87-96 ◽  
Author(s):  
Ana E Vázquez ◽  
Ana M Jimenez ◽  
Glen K Martin ◽  
Anne E Luebke ◽  
Brenda L Lonsbury-Martin
Keyword(s):  
Otoacoustic Emissions ◽  
Noise Exposure ◽  
Distortion Product Otoacoustic Emissions ◽  
Cochlear Function ◽  
Distortion Product

Early Changes in Auditory Function As a Result of Platinum Chemotherapy: Use of Extended High-Frequency Audiometry and Evoked Distortion Product Otoacoustic Emissions

2007 ◽  
Vol 25 (10) ◽  
pp. 1190-1195 ◽  
Author(s):  
Kristin R. Knight ◽  
Dale F. Kraemer ◽  
Christiane Winter ◽  
Edward A. Neuwelt
Keyword(s):  
High Frequency ◽  
Otoacoustic Emissions ◽  
Distortion Product Otoacoustic Emissions ◽  
Auditory Function ◽  
Cochlear Function ◽  
Serial Measurement ◽  
Distortion Product ◽  
High Frequency Audiometry ◽  
Platinum Based Chemotherapy ◽  
Platinum Chemotherapy

Purpose The objective is to describe progressive changes in hearing and cochlear function in children and adolescents treated with platinum-based chemotherapy and to begin preliminary evaluation of the feasibility of extended high-frequency audiometry and distortion product otoacoustic emissions for ototoxicity monitoring in children. Patients and Methods Baseline and serial measurement of conventional pure-tone audiometry (0.5 to 8 kHz) and evoked distortion product otoacoustic emissions (DPOAEs) were conducted for 32 patients age 8 months to 20 years who were treated with cisplatin and/or carboplatin chemotherapy. Seventeen children also had baseline and serial measurement of extended high-frequency (EHF) audiometry (9 to 16 kHz). Audiologic data were analyzed to determine the incidence of ototoxicity using the American Speech-Language-Hearing Association criteria, and the relationships between the different measures of ototoxicity. Results Of the 32 children, 20 (62.5%) acquired bilateral ototoxicity in the conventional frequency range during chemotherapy treatment, and 26 (81.3%) had bilateral decreases in DPOAE amplitudes and dynamic range. Of the 17 children with EHF audiometry results, 16 (94.1%) had bilateral ototoxicity in the EHF range. Pilot data suggest that EHF thresholds and DPOAEs show ototoxic changes before hearing loss is detected by conventional audiometry. Conclusion EHF audiometry and DPOAEs have the potential to reveal earlier changes in auditory function than conventional frequency audiometry during platinum chemotherapy in children.

scholarly journals Time-domain analysis of distortion-product otoacoustic emissions using a hydrodynamic cochlea model

2017 ◽  
Vol 3 (2) ◽  
pp. 453-456
Author(s):  
Dennis Zelle ◽  
Ernst Dalhoff ◽  
Anthony W. Gummer
Keyword(s):  
Time Domain ◽  
Otoacoustic Emissions ◽  
Short Pulse ◽  
Human Subjects ◽  
Time Domain Analysis ◽  
Distortion Product Otoacoustic Emissions ◽  
Sound Waves ◽  
Cochlear Function ◽  
Distortion Product ◽  
The Time Domain

AbstractAs a by-product of nonlinear amplification in the cochlea, the inner ear emits sound waves in response to two tones with different frequencies. These sound waves are measurable in the ear canal as distortion-product otoacoustic emissions (DPOAEs). DPOAEs putatively consist of two components emerging at different locations in the cochlea. Wave interference between the two components limits the accuracy of DPOAEs as a noninvasive measure of cochlear function. Using short stimulus pulses instead of continuous stimuli, the two DPOAE components can be separated in the time domain due to their different latencies. The present work utilizes a nonlinear hydrodynamic cochlea model to simulate short-pulse DPOAEs in the time domain. When adding irregularities to the mechanical parameters of the model, the simulated DPOAE signals show two distinguishable components and long-lasting beat tones, similar to band-pass filtered experimental data from normal-hearing human subjects. The model results suggest that the beat tones can occur solely due to interference of the coherent-reflection component with the fading nonlinear-distortion component.

scholarly journals Subclinical Auditory Dysfunction: Relationship Between Distortion Product Otoacoustic Emissions and the Audiogram

2021 ◽  
pp. 1-16
Author(s):  
Naomi F. Bramhall ◽  
Garnett P. McMillan ◽  
Amy N. Mashburn
Keyword(s):  
Otoacoustic Emissions ◽  
Pure Tone ◽  
Noise Exposure ◽  
Outer Hair Cell ◽  
Self Report ◽  
Distortion Product Otoacoustic Emissions ◽  
Sample Mean ◽  
Distortion Product ◽  
Clinically Normal ◽  
Auditory Physiology

Purpose Distortion product otoacoustic emissions (DPOAEs) and audiometric thresholds have been used to account for the impacts of subclinical outer hair cell (OHC) dysfunction on auditory perception and measures of auditory physiology. However, the relationship between DPOAEs and the audiogram is unclear. This study investigated this relationship by determining how well DPOAE levels can predict the audiogram among individuals with clinically normal hearing. Additionally, the impacts of age, noise exposure, and the perception of tinnitus on the ability of DPOAE levels to predict the audiogram were evaluated. Method Suprathreshold DPOAE levels from 1 to 10 kHz and pure-tone thresholds from 0.25 to 16 kHz were measured in 366 ears from 194 young adults (19–35 years old) with clinically normal audiograms and middle ear function. The measured DPOAE levels at all frequencies were used to predict pure-tone thresholds at each frequency. Participants were grouped by age, self-reported noise exposure/Veteran status, and self-report of tinnitus. Results Including DPOAE levels in the pure-tone threshold prediction model improved threshold predictions at all frequencies from 0.25 to 16 kHz compared with a model based only on sample mean pure-tone thresholds, but these improvements were modest. DPOAE levels for f 2 frequencies of 4 and 5 kHz were particularly influential in predicting pure-tone thresholds above 4 kHz. However, prediction accuracy varied based on participant characteristics. On average, predicted pure-tone thresholds were better than measured thresholds among Veterans, individuals with tinnitus, and the oldest age group. Conclusions These results indicate a complex relationship between DPOAE levels and the audiogram. Underestimation of pure-tone thresholds for some groups suggests that additional factors other than OHC damage may impact thresholds among individuals within these categories. These findings suggest that DPOAE levels and pure-tone thresholds may differ in terms of how well they reflect subclinical OHC dysfunction. Supplemental Material https://doi.org/10.23641/asha.13564745

Hearing loss in vestibular schwannomas: analysis of cochlear function by means of distortion-product otoacoustic emissions

2009 ◽  
Vol 36 (6) ◽  
pp. 644-648 ◽  
Author(s):  
Gian Gaetano Ferri ◽  
Giovanni Carlo Modugno ◽  
Fabio Calbucci ◽  
Alberto Rinaldi Ceroni ◽  
Antonio Pirodda
Keyword(s):  
Hearing Loss ◽  
Otoacoustic Emissions ◽  
Vestibular Schwannomas ◽  
Distortion Product Otoacoustic Emissions ◽  
Cochlear Function ◽  
Distortion Product

scholarly journals Reliability of Contralateral Suppression in Evoked Distortion Product Otoacoustic Emissions

2021 ◽  
Author(s):  
Ana Carolina dos Santos ◽  
Ludimila Labanca ◽  
Larissa Resende Assumpção ◽  
Patricia Cotta Mancini ◽  
Sirley Alves da Silva Carvalho ◽  
...  
Keyword(s):  
Otoacoustic Emissions ◽  
Auditory Pathway ◽  
Inhibitory Effect ◽  
Wilcoxon Test ◽  
Distortion Product Otoacoustic Emissions ◽  
Cochlear Function ◽  
Cross Sectional ◽  
Distortion Product ◽  
Clinical Applicability ◽  
Contralateral Suppression

Abstract Introduction Distortion product otoacoustic emissions (DPOAE) and their suppression may be considered useful in monitoring cochlear function and the efferent auditory pathway inhibitory effect. Nonetheless, the establishment of reliable parameters of response variations is of great importance. Objectives To verify the replicability of test and retest in the research of the inhibitory effect of the efferent pathway using contralateral suppressing stimulus during DPOAE recording for clinical applicability. Methods Cross-sectional study with 48 volunteers, aged 18 to 30 years, with normal audiometric thresholds. The procedures included were audiometric and immittance measures to overrule any conductive or sensorineural conditions and DPOAE recordings without and with contralateral suppression with a 60 dBHL white noise. Distortion product otoacoustic emissions amplitudes were analyzed and compared in both conditions with Wilcoxon test, and the Spearman correlation test was used to assess test-retest reliability. Results The comparative analysis showed differences between amplitudes in test and retest conditions only in 1,500 Hz for DPOAE measures with all other tested frequencies showing no differences, and no difference was observed in all recorded frequencies in the test and retest comparison for DPOAE suppression. The degree of correlation between test and retest of DPOAE amplitude was good at 6,000 Hz and strong (r > 0.880) at the other frequencies. For DPOAE with suppression, all frequencies presented strong correlation between test and retest: 1,500 Hz (r = 0.880), 2,000 Hz (r = 0.882), 3,000 Hz (r = 0.940), and 6,000 Hz (r = 0.957). Conclusions The study found good replicability in contralateral suppression of DPOAE with potential clinical applicability, and we recommend conducting the test from 2000Hz to higher frequencies for more reliable results.

Effect of Acoustic Tumor Extension into the Internal Auditory Canal on Distortion-Product Otoacoustic Emissions

2002 ◽  
Vol 111 (10) ◽  
pp. 912-915 ◽  
Author(s):  
A. Onur Odabasi ◽  
Fred F. Telischi ◽  
Barden Stagner ◽  
Orlando Gomez-Marin ◽  
Glen Martin
Keyword(s):  
Otoacoustic Emissions ◽  
Internal Auditory Canal ◽  
Distortion Product Otoacoustic Emissions ◽  
Negative Effects ◽  
Cochlear Function ◽  
Tumor Extension ◽  
Distortion Product ◽  
Acoustic Neuromas ◽  
Tumor Involvement ◽  
Acoustic Tumor

We studied the effects on distortion-product otoacoustic emissions (DPOAEs) of internal auditory canal (IAC) extension of acoustic neuromas (ANs) with the hypothesis that cochlear patterns of DPOAEs would be more commonly observed when the IAC was completely filled with tumor because of direct tumor involvement of either the inner ear or its blood supply. In a retrospective analysis of 86 patients with surgically proven ANs, DPOAEs were classified as having cochlear or noncochlear patterns on the basis of comparisons with the behavioral pure tone thresholds. The results of behavioral audiometry and DPOAEs were compared with the extension of the tumor into the IAC, which was categorized as full or partial. Of the 86 patients, 58 had tumors with full IAC extension, and 28 had tumors with partial IAC involvement. Cochlear patterns of DPOAEs were found in 55.2% of the tumors in the full IAC group and in 71.4% of those in the partial IAC group (not statistically different). It was concluded that the extent of IAC involvement by ANs was not significantly related to the negative effects of the tumor on cochlear function as represented by DPOAEs.

Sign in / Sign up

Export Citation Format

Share Document